Crystalvue Medical Corporation (TPEX:6527)
Taiwan · Delayed Price · Currency is TWD 74.70
-0.30 (-0.40%)
Aug 19, 2026, 1:30 PM CST
Crystalvue Medical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 148.53 | 146.98 | 127.15 | 103.4 | 115.03 | 77.24 |
Depreciation & Amortization | 11.43 | 15.64 | 27 | 28.09 | 25.37 | 40.34 |
Other Amortization | 2.09 | 2.18 | 2.35 | 1.09 | 0.79 | 0.54 |
Loss (Gain) From Sale of Assets | - | -0.28 | - | - | - | -13.95 |
Stock-Based Compensation | - | - | 3.88 | 19.91 | - | - |
Other Operating Activities | 2.31 | 3.47 | -5.94 | -5.59 | 4.17 | 6.45 |
Change in Accounts Receivable | 41.63 | -56.86 | -62.85 | 36.55 | -50.42 | -13.33 |
Change in Inventory | -58.79 | 6.41 | 26.11 | -29.2 | -61.17 | -37.63 |
Change in Accounts Payable | 1.36 | -0.41 | 21.06 | 0.45 | 16.56 | -20.19 |
Change in Unearned Revenue | 2.03 | -13.53 | 1.63 | 1.47 | 1.31 | 6.94 |
Change in Other Net Operating Assets | 10.6 | 35.53 | 12.67 | -2.14 | 0.13 | 16.84 |
Operating Cash Flow | 161.19 | 139.13 | 153.06 | 154.01 | 51.76 | 63.26 |
Operating Cash Flow Growth | 2.69% | -9.10% | -0.62% | 197.53% | -18.17% | -24.28% |
Capital Expenditures | -200.78 | -184.04 | -130.44 | -4.37 | -7.52 | -351.17 |
Sale of Property, Plant & Equipment | - | 0.28 | - | - | - | - |
Sale (Purchase) of Intangibles | -0.34 | -1.15 | -1.6 | -4.18 | -1.49 | 68.37 |
Investment in Securities | -4.76 | - | - | 0.17 | -0.59 | - |
Other Investing Activities | -0.22 | -0.07 | 3.41 | -0.75 | 5.08 | 88.88 |
Investing Cash Flow | -206.1 | -184.98 | -128.63 | -9.12 | -4.52 | -193.91 |
Long-Term Debt Repaid | - | -6.76 | -6.57 | -6.38 | -6.2 | -6.03 |
Net Debt Issued (Repaid) | 23.14 | -6.76 | -6.57 | -6.38 | -6.2 | -6.03 |
Issuance of Common Stock | - | - | 2.73 | 15.05 | - | - |
Repurchase of Common Stock | - | - | - | - | -11.97 | - |
Common Dividends Paid | -57.02 | -57.02 | -52.3 | -56.76 | -46.3 | -33.41 |
Financing Cash Flow | -33.88 | -63.78 | -56.13 | -48.09 | -64.47 | -39.44 |
Net Cash Flow | -78.79 | -109.62 | -31.71 | 96.8 | -17.23 | -170.09 |
Free Cash Flow | -39.6 | -44.91 | 22.62 | 149.64 | 44.24 | -287.91 |
Free Cash Flow Growth | - | - | -84.89% | 238.26% | - | - |
Free Cash Flow Margin | -4.53% | -4.73% | 2.61% | 18.16% | 5.56% | -39.90% |
Free Cash Flow Per Share | -1.53 | -1.74 | 0.88 | 5.92 | 1.73 | -11.35 |
Levered Free Cash Flow | -65.44 | -77.53 | -13 | 115.66 | 7.49 | -226.8 |
Unlevered Free Cash Flow | -65.22 | -77.24 | -12.61 | 116.17 | 8.12 | -226.07 |
Cash Interest Paid | 0.34 | 0.45 | 0.63 | 0.82 | 1 | 1.17 |
Cash Income Tax Paid | 32.7 | 28.56 | 38.17 | 21.94 | 23.24 | 25.48 |
Change in Working Capital | -3.17 | -28.86 | -1.38 | 7.12 | -93.59 | -47.36 |